304 related articles for article (PubMed ID: 9821235)
21. Anticholinergic bronchodilators.
Witek TJ
Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
[TBL] [Abstract][Full Text] [Related]
22. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
23. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
Grzanka A; Pitsch T; Krzywiecki A; Rogala B
Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
[TBL] [Abstract][Full Text] [Related]
24. [Chronic obstructive lung diseases in patients with ischemic heart disease: a 15-year study].
Kozlova LI; Buzunov RV; Chuchalin AG
Ter Arkh; 2001; 73(3):27-32. PubMed ID: 11417176
[TBL] [Abstract][Full Text] [Related]
25. Maintenance therapy for obstructive lung disease. How to achieve the best response with the fewest agents.
Jacobs M
Postgrad Med; 1994 Jun; 95(8):87-90, 93-6, 99. PubMed ID: 8202425
[TBL] [Abstract][Full Text] [Related]
26. [The effect of the inhalation of a single atrovent dose on pulmonary ventilation function and respiratory mechanics in patients with chronic obstructive bronchitis].
Tetenev FF; Cherniavskaia GM
Ter Arkh; 1989; 61(8):53-5. PubMed ID: 2531477
[TBL] [Abstract][Full Text] [Related]
27. [ Pediatric patients with bronchiolitis or obstructive bronchitis].
Korppi M; Reijonen T; Remes K
Duodecim; 1996; 112(24):2375-82. PubMed ID: 10605238
[No Abstract] [Full Text] [Related]
28. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
29. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease.
Rodríguez-Carballeira M; Heredia JL; Gomez L; Quintana S; Vinas C
Pulm Pharmacol Ther; 1999; 12(1):43-8. PubMed ID: 10447370
[TBL] [Abstract][Full Text] [Related]
30. [Clinical use of atrovent].
Zamotaev IP; Maksimova LN
Klin Med (Mosk); 1984 Apr; 62(4):50-4. PubMed ID: 6234428
[No Abstract] [Full Text] [Related]
31. [The use of Atrovent for the prevention prophylaxis of the bronchospasm (author's transl)].
Papathéodossiou N
Schweiz Rundsch Med Prax; 1979 Jun; 68(23):740-2. PubMed ID: 156357
[No Abstract] [Full Text] [Related]
32. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
Verstraeten JM
Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
[No Abstract] [Full Text] [Related]
33. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
Salikova VV; Nonikov VE; Belousov IuB
Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
[TBL] [Abstract][Full Text] [Related]
34. [Influence of muscarinic receptors and calcium channel blockers on bronchial reactivity and ventilation parameters in patients with obstructive lung diseases].
Siergiejko Z; Kazberuk M; Hofman J; Chyrek-Borowska S
Pneumonol Alergol Pol; 1991; 59(9-10):28-32. PubMed ID: 1843643
[TBL] [Abstract][Full Text] [Related]
35. [The bronchdilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis (author's transl)].
Tabori D; Conkic B; Todic V; Mijatovic M; Mirkovc S; Zecević D; Camprag D
Arzneimittelforschung; 1977; 27(12):55-60. PubMed ID: 576833
[TBL] [Abstract][Full Text] [Related]
36. Acute exacerbations of chronic bronchitis: focusing management for optimum results.
Aboussouan LS
Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417
[TBL] [Abstract][Full Text] [Related]
37. [Respiratory rehabilitation in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in Kinshasa].
Muzembo Ndundu J; Nkakudulu Bikuku H; Frans A
Rev Pneumol Clin; 2001 Jun; 57(3):209-18. PubMed ID: 11416804
[TBL] [Abstract][Full Text] [Related]
38. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers.
Chrischilles E; Gilden D; Kubisiak J; Rubenstein L; Shah H
Am J Manag Care; 2002 Oct; 8(10):902-11. PubMed ID: 12395958
[TBL] [Abstract][Full Text] [Related]
39. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
Brophy C; Kastelik J; Gardiner E; Greenstone M
Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
[TBL] [Abstract][Full Text] [Related]
40. [Use of dosage-aerosols in the treatment of obstructive respiratory tract diseases].
Frank A
Wien Med Wochenschr; 1977 May; 127(10):309-13. PubMed ID: 141791
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
